Home LiteratureArticle Details
PMID: 9627671 Published · ppublish English Comparative Study Journal Article

Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series.

Anti-cancer drug design ·Vol. 13 ·No. 4 ·1998-06-00 ·页码 317-36

Etievant C, Schambel P, Guminski Y, Barret JM, Imbert T, Hill BT

Abstract

Podophyllotoxin and epipodophyllotoxin react with tubulin at the same binding site as colchicine, but in contrast to colchicine, do not appear to exert their cytotoxicities by mechanisms dependent on P-glycoprotein (Pgp) expression. To investigate structural requirements for Pgp recognition a series of podophyllotoxin and epipodophyllotoxin derivatives have been synthesized. Their interactions with the multidrug resistance-related protein Pgp have been studied by evaluating their relative cytotoxicities versus P388-sensitive murine leukemic cells and a classic multidrug-resistant (MDR) Pgp-overexpressing subline (P388/ADR), and their relative tubulin polymerization inhibitory activities against microtubular proteins have been determined. Based on tridimensional structure-activity relationships within this series of compounds, structural requirements for Pgp recognition have been identified. Moreover, proposals are made for extending these criteria to other chemical classes of anticancer drugs.

MeSH 主题词
ATP Binding Cassette Transporter, Subfamily B, Member 1/chemistry Animals Antineoplastic Agents, Phytogenic/pharmacology Mice Microtubule Proteins/chemistry Models, Molecular Podophyllotoxin/analogs & derivatives,chemical synthesis,pharmacology Structure-Activity Relationship Tubulin/chemistry Tumor Cells, Cultured
化学物质
ATP Binding Cassette Transporter, Subfamily B, Member 1 Antineoplastic Agents, Phytogenic Microtubule Proteins Tubulin Podophyllotoxin
作者与单位
共 6 位作者,点击展开单位 / ORCID
Etievant C
Division de Cancérologie Experimentale I, Centre de Recherche Pierre Fabre, Castres, France.
Schambel P
Guminski Y
Barret J M
Imbert T
Hill B T
Article Info
Journal
Anti-cancer drug design
Abbr.
Anticancer Drug Des
ISSN
0266-9536
Published
1998-06-00
页码
317-36
Language
English
Country/Region
United States
NLM ID
8603523
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]